Compile Data Set for Download or QSAR
maximum 50k data
Found 123 of ic50 data for polymerid = 50000995,1436
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM615970(US20230271957, Example 2)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM618476(US20230286978, Example 12)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco s PBS buffer in a final assay volume of 20 µL. ARM-SAM-TIR lysate wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616002(US20230271957, Example 6)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616017(US20230271957, Example 7)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616032(US20230271957, Example 9)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616033(US20230271957, Example 10)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616034(US20230271957, Example 11)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616035(US20230271957, Example 12)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616036(US20230271957, Example 13)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616037(US20230271957, Example 14)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616038(US20230271957, Example 15)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616039(US20230271957, Example 16)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616040(US20230271957, Example 17)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616042(US20230271957, Example 19)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM618465(US20230286978, Example 1)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco s PBS buffer in a final assay volume of 20 µL. ARM-SAM-TIR lysate wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM618468(US20230286978, Example 4)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco s PBS buffer in a final assay volume of 20 µL. ARM-SAM-TIR lysate wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM618469(US20230286978, Example 5)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco s PBS buffer in a final assay volume of 20 µL. ARM-SAM-TIR lysate wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM618474(US20230286978, Example 10)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco s PBS buffer in a final assay volume of 20 µL. ARM-SAM-TIR lysate wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM615974(US20230271957, Example 3)
Affinity DataIC50: <100nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM651662(US20240051939, Compound I-2)
Affinity DataIC50:  300nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM651661(US20240051939, Compound I-1)
Affinity DataIC50:  300nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM615916(US20230271957, Example 1)
Affinity DataIC50:  550nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616031(US20230271957, Example 8)
Affinity DataIC50:  550nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616041(US20230271957, Example 18)
Affinity DataIC50:  550nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM616043(US20230271957, Example 20)
Affinity DataIC50:  550nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco's PBS buffer in a final assay volume of 20 μL. ARM-SAM-TIR l...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM618477(US20230286978, Example 13)
Affinity DataIC50:  550nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco s PBS buffer in a final assay volume of 20 µL. ARM-SAM-TIR lysate wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM618467(US20230286978, Example 3)
Affinity DataIC50:  550nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco s PBS buffer in a final assay volume of 20 µL. ARM-SAM-TIR lysate wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM618470(US20230286978, Example 6)
Affinity DataIC50:  550nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco s PBS buffer in a final assay volume of 20 µL. ARM-SAM-TIR lysate wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM618473(US20230286978, Example 9)
Affinity DataIC50:  550nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco s PBS buffer in a final assay volume of 20 µL. ARM-SAM-TIR lysate wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM618475(US20230286978, Example 11)
Affinity DataIC50:  550nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco s PBS buffer in a final assay volume of 20 µL. ARM-SAM-TIR lysate wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM618466(US20230286978, Example 2)
Affinity DataIC50:  550nMAssay Description:The enzymatic assay was performed in a 384-well polypropylene plate in Dulbecco s PBS buffer in a final assay volume of 20 µL. ARM-SAM-TIR lysate wit...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600553(US11629136, Example 1)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1(Homo sapiens)
Disarm Therapeutics

US Patent
LigandPNGBDBM50058655(1,1',1'',1'''-[disulfanediylbis(carbonothioylnitri...)
Affinity DataIC50: <1.00E+3nMAssay Description:First, 200 μM of the compound was added to a 50 mM Tris-HCl (pH 7.5) solution containing 0.05 μg/ml dN-SARM1. Then half of the mixture was ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600557(US11629136, Example 5)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600558(US11629136, Example 5a)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600560(US11629136, Example 6)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600561((S)-2,2,2-Trifluoro-1-(5-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600562((S)-2,2,2-Trifluoro-1-(5-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600567(US11629136, Example 12)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600571((S)-2,2,2-Trifluoro-1-(4-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600580((S)-(4-(Pyridin-4-ylmethyl)-1H-imidazol-2-yl)(thia...)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600583(US11629136, Example 23)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600584(US11629136, Example 24)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600586(US11629136, Example 24b)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600588(US11629136, Example 25)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600590((R)-2,2,2-Trifluoro-1-(4-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600591(US11629136, Example 27)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600598((R)-1,1,1-Trifluoro-2-(5-(pyridin-4-ylmethyl)-1H-i...)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600605(US11629136, Example 36)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetNAD(+) hydrolase SARM1 [50-724](Homo sapiens (Human))
Nura Bio

US Patent
LigandPNGBDBM600607((S)-2,2,2-Trifluoro-1-(4-((3-methylpyridin-4-yl)me...)
Affinity DataIC50: <1.00E+3nMAssay Description:Each reaction was run at a volume of 20 μL containing 50 μM compound (dissolved in DMSO; final concentration of DMSO is 1% v/v), 40 nM huma...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 123 total ) | Next | Last >>
Jump to: